Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
David Berman, Teaching Note
Raman, Ananth; Gaur, Vishal; Kesavan, SaravananNota del Instructor HBS-609006-EServicios y operacionesTeaching Note for [605081].Desde 0,00 €
-
Airbus A380--Turbulence Ahead
Raman, Ananth; Schmidt, William; Gaur, VishalCaso HBS-609041-EMultiple delays of the Airbus A380 have shocked analysts and investors alike. What are the causes of these delays and how should investors respond to the signals they may be sending about the company's outlook?Desde 8,20 €
-
Coca-Cola in Vietnam
Goh, Joel; Raman, AnanthCaso HBS-616063-EServicios y operacionesDesde 8,20 €
-
Merck: Operating Science-Based Business
Raman, Ananth; Maurer, Inga; Schmidt, WilliamCaso HBS-612082-EServicios y operacionesMerck is known for its commitment to investing in basic R&D. Are Merck's long-term investments justifiable when the firm faces extreme earnings pressure?Desde 8,20 €
-
Inventory-Based Lending Industry Note
Foley, C. Fritz; Raman, Ananth; Craig, Nathan C.Caso HBS-612057-EServicios y operacionesInventory-based lending is a form of asset-based lending used by retailers and wholesalers. This note describes the development and the current state of the inventory-based lending industry.Desde 8,20 €
-
Axis My India
Raman, Ananth; Winslow, Ann B.; Dey, KairaviCaso HBS-621075-EServicios y operacionesPradeep Gupta founded Axis My India (AMI) as a printing and publishing company in 1998. In 2013, AMI expanded into consumer research and election forecasting. Although a relatively unknown entity, AMI predicted several election results accurately. Gupta describes AMI's rigorous process of research, primary data collection from each constituency, quality checking of data by auditors and data analysis. AMI partnered with India Today Group to broadc...Desde 8,20 €
-
Merck: Investing in Science-Based Business (Abridged)
Raman, Ananth; Maurer, IngaCaso HBS-611027-EServicios y operacionesRay Gilmartin faces a dilemma. His company's credibility has been damaged by the recent withdrawal of Vioxx, a multi-billion dollar drug. Moreover, the withdrawal of Vioxx would imply that Merck would fail to meet analysts' earnings expectations for 2005 unless Gilmartin cuts the R&D budget. Cutting the budget might hurt morale and productivity in Merck labs.Desde 8,20 €
-
AREVA T&D
Raman, Ananth; Dessain, Vincent; Damgaard Jensen, Ane; Kristinsdottir, Gudrun UrfalinoCaso HBS-608174-ETo maximize their effectiveness, color cases should be printed in color. The case explores the rapid and highly effective turnaround at AREVA's transmission and distribution (T&D) business by focusing on the division's operations. The division was struggling in 2004 when newly-appointed CEO Philippe Guillemot and his team improved performance substantially by focusing on four levers - industrial footprint realignment, competitive sourcing, proces...Desde 8,20 €
-
SCMS: Battling HIV/AIDS in Africa
Raman, Ananth; Watson, Noel; Kraiselburd, Santiago; Akili, EmmanuelCaso HBS-613023-EServicios y operacionesIn 2005, USAID and the U.S. President s Emergency Plan for AIDS Relief (PEPFAR), created the Supply Chain Management System (SCMS) to procure and distribute essential medicines and supplies; provide technical assistance to transform existing supply chains; and collaborated with in-country and global partners to coordinate efforts. The new US Global Health Initiative (GHI) initialized in 2010 sought to build on these efforts through strengthened ...Desde 8,20 €
-
Beijing's Terminal 3: Building a New Gateway to China
Fearing, Douglas; Raman, Ananth; Donovan, G.A.Caso HBS-613051-EIniciativa emprendedoraDesde 8,20 €